Mohammad Karimi

Mohammad Karimi

Auto-generated profile, based on publicly available information

Mohammad Karimi

Student Research Committee, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
AAAmir R. Afshari
Amir R. Afshari
MJMohammad Jalili-nik
Mohammad Jalili-nik
FAFarzaneh Abbasinezhad-Moud
Farzaneh Abbasinezhad-Moud
HJHossein Javid
Hossein Javid
MKMohammad Karimi
Mohammad Karimi
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar
Glioblastoma Multiforme (GBM) is a poorly curable brain tumor because of its extremely invasive nature. Curcuminoids, as potential phytochemicals extracted from Curcuma Longa L., have been documented for their chemopreventive and antitumor activities against several types of malignancies. These compounds exert these effects via modulation of multiple signaling pathways and molecular targets at different stages of tumor progression, proliferation, and metastasis. In experimental studies, curcuminoids have demonstrated promising therapeutic benefits to overcome GBM. Curcuminoids have been shown to exert their anti-GBM effects through regulation of angiogenesis, apoptosis, autophagy, metastasis, invasion, as well as potential molecular targets, including receptor tyrosine kinases, Sonic Hedgehog, and NF-κB. This study reviews the observations regarding the impact of curcumin and its derivatives on GBM and the potential of translating the research findings into the clinic.